These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 21821115)
1. Genome-wide profiling of DNA methylation in human cancer cells. Ogoshi K; Hashimoto S; Nakatani Y; Qu W; Oshima K; Tokunaga K; Sugano S; Hattori M; Morishita S; Matsushima K Genomics; 2011 Oct; 98(4):280-7. PubMed ID: 21821115 [TBL] [Abstract][Full Text] [Related]
2. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of multidrug resistance 1 gene expression: profiling CpG methylation status using bisulphite sequencing. Baker EK; El-Osta A Methods Mol Biol; 2010; 596():183-98. PubMed ID: 19949925 [TBL] [Abstract][Full Text] [Related]
5. Methylation hot spots in the 5' flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. Qian XC; Brent TP Cancer Res; 1997 Sep; 57(17):3672-7. PubMed ID: 9288770 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation differences associated with tumor tissues identified by genome scanning analysis. Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591 [TBL] [Abstract][Full Text] [Related]
7. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622 [TBL] [Abstract][Full Text] [Related]
8. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines. Guilleret I; Benhattar J Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393 [TBL] [Abstract][Full Text] [Related]
9. A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse. Suzuki M; Sato S; Arai Y; Shinohara T; Tanaka S; Greally JM; Hattori N; Shiota K Genes Cells; 2007 Dec; 12(12):1305-14. PubMed ID: 18076568 [TBL] [Abstract][Full Text] [Related]
10. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells. Tryndyak V; Kovalchuk O; Pogribny IP Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473 [TBL] [Abstract][Full Text] [Related]
11. Determining the effect of DNA methylation on gene expression in cancer cells. Lee CJ; Evans J; Kim K; Chae H; Kim S Methods Mol Biol; 2014; 1101():161-78. PubMed ID: 24233782 [TBL] [Abstract][Full Text] [Related]
12. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma. Kao RH; Huang LC; Hsu YH Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040 [TBL] [Abstract][Full Text] [Related]
13. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing. Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420 [TBL] [Abstract][Full Text] [Related]
14. DBCAT: database of CpG islands and analytical tools for identifying comprehensive methylation profiles in cancer cells. Kuo HC; Lin PY; Chung TC; Chao CM; Lai LC; Tsai MH; Chuang EY J Comput Biol; 2011 Aug; 18(8):1013-7. PubMed ID: 21214365 [TBL] [Abstract][Full Text] [Related]
15. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589 [TBL] [Abstract][Full Text] [Related]
16. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer. Smith JF; Mahmood S; Song F; Morrow A; Smiraglia D; Zhang X; Rajput A; Higgins MJ; Krumm A; Petrelli NJ; Costello JF; Nagase H; Plass C; Held WA Epigenetics; 2007 Sep; 2(3):161-72. PubMed ID: 17965620 [TBL] [Abstract][Full Text] [Related]
17. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) residing in mouse pluripotent stem cells. Sato S; Yagi S; Arai Y; Hirabayashi K; Hattori N; Iwatani M; Okita K; Ohgane J; Tanaka S; Wakayama T; Yamanaka S; Shiota K Genes Cells; 2010 Jun; 15(6):607-18. PubMed ID: 20477876 [TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Gonzalgo ML; Liang G; Spruck CH; Zingg JM; Rideout WM; Jones PA Cancer Res; 1997 Feb; 57(4):594-9. PubMed ID: 9044832 [TBL] [Abstract][Full Text] [Related]
20. Silencing of bidirectional promoters by DNA methylation in tumorigenesis. Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]